当前位置:首页 - 行情中心 - 康华生物(300841) - 财务分析

康华生物

(300841)

  

流通市值:80.12亿  总市值:87.39亿
流通股本:1.22亿   总股本:1.33亿

康华生物(300841)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.21亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益346821.73万元,未分配利润240979.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产388366.76万元,负债41545.03万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入137,942,758.511,431,876,597.941,060,378,720.25741,084,779.28
营业总成本112,232,733.05875,179,262.72577,201,604.21365,393,381.89
营业利润20,064,411.78467,283,753.56462,651,015.19351,413,795.79
利润总额20,057,797.99467,023,387.5462,436,864.13351,302,336.81
净利润20,708,594.7398,651,923.09405,902,226.46306,554,841.9
其他综合收益----
综合收益总额20,708,594.7398,651,923.09405,902,226.46306,554,841.9
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,354,274,529.12,488,001,102.092,360,528,064.572,420,567,909.09
非流动资产合计1,529,393,101.951,539,581,171.881,590,238,876.091,559,139,828.1
资产总计3,883,667,631.054,027,582,273.973,950,766,940.663,979,707,737.19
流动负债合计406,136,311.95566,368,786.34486,031,887.64529,262,593.27
非流动负债合计9,314,028.1213,704,791.359,976,053.379,404,746.55
负债合计415,450,340.07580,073,577.69496,007,941.01538,667,339.82
归属于母公司股东权益合计3,468,217,290.983,447,508,696.283,454,758,999.653,441,040,397.37
股东权益合计3,468,217,290.983,447,508,696.283,454,758,999.653,441,040,397.37
负债和股东权益合计3,883,667,631.054,027,582,273.973,950,766,940.663,979,707,737.19
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计229,416,043.931,616,032,183.261,128,507,441.97744,131,555.23
经营活动现金流出小计246,102,477.91,043,790,285.78875,584,606.5568,340,535.87
经营活动产生的现金流量净额-16,686,433.97572,241,897.48252,922,835.47175,791,019.36
投资活动现金流入小计260,116,367.66102,432,626.7102,026,956.46100,751,291.66
投资活动现金流出小计331,760,357.62444,299,477.28196,580,140.84156,238,542.98
投资活动产生的现金流量净额-71,643,989.96-341,866,850.58-94,553,184.38-55,487,251.32
筹资活动现金流入小计59,793,800237,784,905.68206,344,705.68166,344,705.68
筹资活动现金流出小计89,291,703.23709,579,858.07643,331,666.08557,724,373
筹资活动产生的现金流量净额-29,497,903.23-471,794,952.39-436,986,960.4-391,379,667.32
汇率变动对现金及现金等价物的影响64,558.691,767,174.71,592,860.871,784,397.5
现金及现金等价物净增加额-117,763,768.47-239,652,730.79-277,024,448.44-269,291,501.78
期末现金及现金等价物余额681,949,521.9799,713,290.37762,341,572.72770,074,519.38
最新报告期:2025-05-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券宋硕,陈竹3.574.004.452025-05-06
TOP↑